Diagnostic approach to elevated dd-cfDNA with reassuring EMB in heart transplantation
Despite significant advances in organ preservation, surgical techniques, and immunosuppressive regimens, rejection continues to pose a major challenge in the care of heart transplant patients. Endomyocardial biopsy (EMB) remains the gold standard test for surveillance and diagnosis of rejection, but...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-08-01
|
| シリーズ: | Frontiers in Transplantation |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/frtra.2025.1623514/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
